2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG

Drug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]etamine or 25I-NBOMe was explored using thin la...

Full description

Bibliographic Details
Main Authors: Pâmella F. dos Santos, Lindamara M. Souza, Bianca B. Merlo, Helber B. Costa, Lilian V. Tose, Heloá Santos, Gabriela Vanini, Leandro F. Machado, Rafael S. Ortiz, Renata P. Limberger, Boniek G. Vaz, Wanderson Romão
Format: Article
Language:English
Published: Sociedade Brasileira de Química 2016-02-01
Series:Química Nova
Subjects:
CCD
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422016000200229&lng=en&tlng=en
id doaj-8ce4308da36f44cc9f5712fea16e81b5
record_format Article
spelling doaj-8ce4308da36f44cc9f5712fea16e81b52020-11-24T23:46:15ZengSociedade Brasileira de QuímicaQuímica Nova1678-70642016-02-0139222923710.5935/0100-4042.20150178S0100-404220160002002292-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUGPâmella F. dos SantosLindamara M. SouzaBianca B. MerloHelber B. CostaLilian V. ToseHeloá SantosGabriela VaniniLeandro F. MachadoRafael S. OrtizRenata P. LimbergerBoniek G. VazWanderson RomãoDrug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]etamine or 25I-NBOMe was explored using thin layer chromatography (TLC), ultraviolet-visible spectrophotometry (UV-Vis), attenuated total reflection with Fourier transform infrared spectroscopy(ATR-FTIR), gas chromatography mass spectrometry (GC-MS) and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FT-ICR MS). First, the TLC technique was effective for identifying spots related to 25C-, 25B- and 25I-NBOMe compounds, all with the same retention factor, Rf ≈ 0.50. No spot was detected for 2,5-dimethoxy-4-bromoamphetamine, 2,5-Dimethoxy-4-chloroamphetamine or lysergic acid diethylamide compounds. ATR-FTIR preserved the physical-chemical properties of the material, whereas GC-MS and ESI-MS showed better analytical selectivity. ESI(+)FT-ICR MS was used to identify the exact mass (m/z428.1706 for the [M + H]+ ion), molecular formula (M = C18H22INO3), degree of unsaturation (DBE = 8) and the chemical structure (from collision induced dissociation, CID, experiments) of the 25I-NBOMe compound. Furthermore, the ATR-FTIR and CID results suggested the presence of isomers, where a second structure is proposed as an isomer of the 25I-NBOMe molecule.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422016000200229&lng=en&tlng=endesigner drugs25I-NBOMeCCDATR-FTIRGC-MSESI(+)-FT-ICR MS
collection DOAJ
language English
format Article
sources DOAJ
author Pâmella F. dos Santos
Lindamara M. Souza
Bianca B. Merlo
Helber B. Costa
Lilian V. Tose
Heloá Santos
Gabriela Vanini
Leandro F. Machado
Rafael S. Ortiz
Renata P. Limberger
Boniek G. Vaz
Wanderson Romão
spellingShingle Pâmella F. dos Santos
Lindamara M. Souza
Bianca B. Merlo
Helber B. Costa
Lilian V. Tose
Heloá Santos
Gabriela Vanini
Leandro F. Machado
Rafael S. Ortiz
Renata P. Limberger
Boniek G. Vaz
Wanderson Romão
2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
Química Nova
designer drugs
25I-NBOMe
CCD
ATR-FTIR
GC-MS
ESI(+)-FT-ICR MS
author_facet Pâmella F. dos Santos
Lindamara M. Souza
Bianca B. Merlo
Helber B. Costa
Lilian V. Tose
Heloá Santos
Gabriela Vanini
Leandro F. Machado
Rafael S. Ortiz
Renata P. Limberger
Boniek G. Vaz
Wanderson Romão
author_sort Pâmella F. dos Santos
title 2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
title_short 2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
title_full 2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
title_fullStr 2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
title_full_unstemmed 2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
title_sort 2-(4-iodo-2,5-dimetoxifenil)-n-[(2-metoxifenil)metil]etamina ou 25i-nbome: caracterização química de uma designer drug
publisher Sociedade Brasileira de Química
series Química Nova
issn 1678-7064
publishDate 2016-02-01
description Drug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]etamine or 25I-NBOMe was explored using thin layer chromatography (TLC), ultraviolet-visible spectrophotometry (UV-Vis), attenuated total reflection with Fourier transform infrared spectroscopy(ATR-FTIR), gas chromatography mass spectrometry (GC-MS) and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FT-ICR MS). First, the TLC technique was effective for identifying spots related to 25C-, 25B- and 25I-NBOMe compounds, all with the same retention factor, Rf ≈ 0.50. No spot was detected for 2,5-dimethoxy-4-bromoamphetamine, 2,5-Dimethoxy-4-chloroamphetamine or lysergic acid diethylamide compounds. ATR-FTIR preserved the physical-chemical properties of the material, whereas GC-MS and ESI-MS showed better analytical selectivity. ESI(+)FT-ICR MS was used to identify the exact mass (m/z428.1706 for the [M + H]+ ion), molecular formula (M = C18H22INO3), degree of unsaturation (DBE = 8) and the chemical structure (from collision induced dissociation, CID, experiments) of the 25I-NBOMe compound. Furthermore, the ATR-FTIR and CID results suggested the presence of isomers, where a second structure is proposed as an isomer of the 25I-NBOMe molecule.
topic designer drugs
25I-NBOMe
CCD
ATR-FTIR
GC-MS
ESI(+)-FT-ICR MS
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422016000200229&lng=en&tlng=en
work_keys_str_mv AT pamellafdossantos 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT lindamaramsouza 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT biancabmerlo 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT helberbcosta 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT lilianvtose 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT heloasantos 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT gabrielavanini 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT leandrofmachado 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT rafaelsortiz 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT renataplimberger 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT boniekgvaz 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
AT wandersonromao 24iodo25dimetoxifeniln2metoxifenilmetiletaminaou25inbomecaracterizacaoquimicadeumadesignerdrug
_version_ 1725494026600185856